02.10.2012 • NewsAbbottlawsuitspharmaceutical industry

U.S. Judge Approves $700 Million in Abbott Depakote Fines

A federal judge on Tuesday sentenced Abbott Laboratories to pay $700 million in fines and other costs for illegal marketing of its drug Depakote, in connection with a previously announced settlement, the U.S. Justice Department said.

The pharmaceutical maker said in May it would plead guilty to a misdemeanor violation of misbranding.

Under terms announced then, Abbott agreed to pay $800 million in a civil settlement, a $700 million criminal penalty and $100 million to U.S. states to resolve consumer protection matters

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.